Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells

Experimental Cell Research

Volumn 246, Issue 2, 1999, Pages 471-479

  McClellan, Maryanne ^b   Kievit, Paul ^a   Auersperg, Nelly ^c   Rodland, Karin ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b REED COLLEGE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN C FOS; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; EARLY RESPONSE GENE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

EID: 0033080444     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4328     Document Type: Article

References (69)

1. Rabinerson D., Kaplan B., Levavi H., Neri A. The biology of ovarian cancer of epithelial origin. Isr. J. Med. Sci. 32:1996;1128-1133.
2. Ackerman R. C., Murdoch W. J. Prostaglandin-induced apoptosis of ovarian surface epithelial cells. Prostaglandins. 45:1993;475-485.
3. Karlan B. Y., Jones J., Greenwald M., Lagasse L. D. Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro. Am. J. Obstet. Gynecol. 173:1995;97-104.
4. Jindal S. K., Ishii E., Letarte M., Vera S., Teerds K. J., Dorrington J. H. Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol. Reprod. 52:1995;1027-1037.
5. Kieback D. G., Press M. F., McCamant S. K., Atkinson E. N., Mobus V. J., Runnebaum I. B., Kreienberg R., Jones L. A. Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression. Gerburtshilfe-Frauenheilkd. 55:1995;189-194.
6. van der Burg M. E., Henzen-Logmans S. C., Foekens J. A., Berns E. M., Rodenberg C. J., van Putten W. L., Klijn J. G. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand-binding assays, in primary epithelial ovarian cancer: a pilot study. Eur. J. Cancer. 29:1993;1951-1957.
7. Scambia G., Benedetti R., Panci P., Battaglia F., Ferrandina G., Baiocchi G., Greggi S., De Vincenzo R., Mancuso S. Significance of epidermal growth factor receptor in advanced ovarian cancer. J. Clin. Oncol. 10:1992;529-535.
8. Meden H., Marx D., Raab T., Kron M., Schauer A., Kuhn W. EGF-R and overexpression of the oncogene c-erb-B-2 in ovarian cancer: Immunohistochemical findings and prognostic value. J. Obstet. Gynaecol. 21:1995;167-178.
9. Bartlett J. M., Langdon S. P., Simpson B. J., Stewart M., Katsaros D., Sismondi P., S L., N S. W., Williams A. R., Lessells A. M., Macleod K. G., Smyth J. F., Miller W. R. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br. J. Cancer. 73:1996;301-306.
10. Meden H., Kuhn W. Overexpression of the oncogene c-erb-B-2 (HER2/neu) in ovarian cancer: A new prognostic factor. Eur. J. Obstet. Gynecol. Reprod. Biol. 71:1997;173-179.
11. Berchuck A., Kamel A., Whitaker R., Kerns B., Olt G., Kinney R., Soper J. T., R D., Clarke-Pearson D. L., P M., S M., S Y., Bast R. C. J. Overexpression of HER-2/neu. Cancer Res. 50:1990;4087-4091.
12. Bauknecht T., Kommoss F., Birmelin G., von Kleist S., Kohler M., Pfeiderer A. Expression analysis of EGFR and TGFα in human ovarian surface epithelial cells. Anticancer Res. 11:1991;1523-1528.
13. van Haaften-Day C., Russell P., Boyer C. M., Kerns B. J., Weiner J. R., Jensen D. N., Bast R. C. J., Hacker N. F. Expression of cell regulatory proteins in ovarian borderline tumors. Cancer. 77:1996;2092-2098.
14. Ziltener H. J., Maines-Bandiera S., Schrader J. W., Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony stimulating factors by human ovarian surface epithelium. Biol. Reprod. 49:1993;635-641.
15. Marth C., Lang T., Koza A., Mayer I., Daxenbixler G. Transforming growth factor-beta and ovarian carcinoma cells: Regulation of proliferation and surface antigen expression. Cancer Lett. 51:1990;221-225.
16. Crew A. J., Lagdon S. P., Miller E. P., Miller W. R. Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF receptor positive human ovarian carcinoma cell lines. Eur. J. Cancer. 28:1992;337-341.
17. Jindal S. K., Snoey D. M., Lobb D. K., Dorrington J. H. Transforming growth factor alpha: Localization and role in the surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol. Oncol. 53:1994;17-23.
18. Chambers S. K., Wang Y., Gertz R. E., Kacinski B. M. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res. 55:1995;1578-1585.
19. Beerli R. R., Ggraus-Porter D., Woods-Cook K., Chen X., Yarden Y., Hynes N. E. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and diplays a differential requirement for ErbB-2. Mol. Cell. Biol. 15:1995;6496-6505.
20. Xu Y., Fang X.-J., Casey G., Mills G. B. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309:1995;933-940.
21. Siemens C. H., Auersperg N. Serial propagation of human ovarian surface epithelium in tissue culture. J. Cell Physiol. 134:1988;347-356.
22. Rodriguez G. C., Berchuck A., Whitaker R. S., Schlossman D., Clarke-Pearson D. L., Bast R. C. J. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. Am. J. Obstet. Gynecol. 164:1991;745-750.
23. Vigne J. L., Halburnt L., Skinner M. K. Characterization of bovine ovarian surface epithelium and stromal cells: Identification of secreted proteins. Biol. Reprod. 51:1994;1213-1221.
24. Tamura M., Sasano H., Suzuke T., Fukaya T., Funayama Y., Takayama K., Takaya R., Yajima A. Expression of epidermal growth factors and epidermal growth factor receptor in normal cycling human ovaries. Human Reprod. 10:1995;1891-1896.
25. van Wezel I. L., Umapathysivam K., Tilley W. D., Rodgers R. J. Immunohistochemical localization of basic fibroblast growth factor in bovine ovarian follicles. Mol. Cell. Endocrinol. 115:1995;133-140.
26. Maines-Bandiera S. L., Kruk P. A., Auersperg N. SV40 transformed human ovarian epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am. J. Obstet. Gynecol. 167:1992;729-735.
27. Edwards S. N., Tolkovsky A. M. Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal. J. Cell Biol. 124:1994;537-546.
28. Rodland K. D., Jue S. F., Magun B. E. Regulation of VL30 gene expression by activators of protein kinase C. J. Biol. Chem. 261:1986;5029-5033.
29. Pribnow D., Muldoon L., Fajardo M., Theodor L., Chen L.-Y. S., Magun B. E. Endothelin induces transcription offos/jun. Mol. Endocrinol. 6:1992;1003-1012.
30. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 337:1989;473-475.
31. Berchuck A., Olt G. J., Everitt L., Soisson A. P., Bast R. C. J., Boyer C. M. The role of peptide growth factors in epithelial ovarian cancer. Obstet. Gynecol. 75:1990;255-262.
32. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
33. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
34. Angel P., Karin M. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
35. Pulverer B. J., Kyriakis J. M., Avrunch J., Nikolakaki E., Woodgett J. R. Phosphorylation of c-jun. Nature. 353:1991;670-674.
36. TCFfos. Nature. 358:1992;414-417.
37. Soares H. D., Curran T., Morgan J. I. Transcription factors as molecular mediators in cell death. Ann. N. Y. Acad. Sci. 747:1994;172-182.
38. Chen Y. R., Meyer C. F., Tan T. H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem. 271:1996;631-634.
39. Ottensmeier C., Swanson L., Stroebel T., Druker B., Niloff J., Cannistra S. A. Absence of constitutive EGF receptor activation in ovarian cancer cell lines. Br. J. Cancer. 74:1996;446-452.
40. Cavigelli M., Dolfi F., Claret F. X., Karin M. Induction of c-fos. EMBO J. 14:1995;5957-5964.
41. Day M. L., Zhao X., Wu S., Swanson P. E., Humphrey P. A. Phorbol-ester induced apoptosis is accompanied by NGF1-A and c-fos. Cell Growth Differ. 5:1994;735-741.
42. Young C. Y., Murtha P. E., Zhang J. Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol. Res. 6:1994;203-210.
43. Dufourny B., Alblas J., van Teeffelen H. A., van Schaik F. M., van der Burg B., Steenbergh P. H., Sussenbach J. S. Mitogenic signaling of isulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem. 272:1997;31163-31171.
44. Garzotto M., White-Jones M., Jiang Y., Ehleiter D., Liao W.C., Haimovitz-Friedman A., Fuks Z., Kolesnick R. 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res. 58:1998;2260-2264.
45. Kyriakis J. M., Banerjee P., Nikolakaki E., Dal T., Ruble E. A., Ahmad M. F., Avruch J., Woodgett J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
46. Rosette C., Karin M. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 274:1996;1194-1197.
47. Seimiya H., Mashima T., Toho M., Tsuro T. c-Jun NH2-terminal kinase mediated activation of interleukin-1-β converting enzyme/CED-3-like protease during anti-cancer drug-induced apoptosis. J. Biol. Chem. 272:1997;4631-4636.
48. Waskiewicz A., Cooper J. A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7:1995;798-805.
49. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., Johnson E. M. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1994;1717-1727.
50. Pang L., Sawasa T., Decker S. J., Saltiel A. R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
51. Pumiglia K. M., Decker S. J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA. 94:1997;448-452.
52. See R. H., Shi Y. Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription. Mol. Cell. Biol. 18:1998;4012-4022.
53. Kennedy S. G., Wagner A. J., Conzen S. D., Jordan J., Bellacosa A., Tsichlis P. N., Hay N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:1997;701-713.
54. Weiss R. H., Yabes A. P. Mitogenic inhibition by phorbol esters is associated with decreased phosphatidylinositol-3 kinase activation. Am. J. Physiol. 270:1996;619-627.
55. Morrison P., Saltiel A. R., Rosner M. R. Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C. J. Biol. Chem. 271:1996;12891-12896.
56. Marshall C. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
57. Cook S. J., McCormick F. Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem. J. 320:1996;237-245.
58. Teng K. K., Lander H., Fajardo J. E., Hanafusa H., Hempstead B. L., Birge B. v-Crk modulation of growth factor-induced PC12 cell differentiation involves the src homology2 domain of v-crk and sustained activation of the ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 270:1995;20677-20685.
59. Goillot E., Raingeaud J., Ranger A., Tepper R.I., Davis R., Harlow E., Sanchez I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA. 94:1997;3302-3307.
60. Minden A., Lin A., Smeal T., D'erijard B., Cobb M., Davis R., Karin M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14:1994;6683-6688.
61. Ormerod M. G., O'Neill C. F., Robertson D., Harrap K. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res. 211:1994;231-237.
62. Milas L., Hunter N. R., Kurdoglu B., Mason K. A., Meyn R. E., Stephens L. C., Peters L. J. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35:1995;297-303.
63. Strobel T., Swanson L., Korsneyer S., Cannistra S. A. BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc. Natl. Acad. Sci. USA. 93:1996;14094-14099.
64. Nash J., Ozols R., Smyth J., Al E. Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet. Gynecol. 73:1989;1009-1016.
65. Potapova O., Haghighi A., Bost F., Liu C., Birrer M. J., Gjerset R., Mercola D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272:1997;14041-14044.
66. Basu A., Teicher B. A., Lazo J. S. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diaminedichloroplatinum (II). J. Biol. Chem. 265:1990;8451-8457.
67. Hirata J., Kikuchi Y., Kita T., Imaizumi E., Toade T., Ishii K., Kudoh K., Nagata I. Modulation of sensitivity of human ovarian cancer cells to cis-diaminedichloroplatinum (II) by 12-0-tetradecanoyl-phorbol-13-acetate and D,L-butathionine-S, R-sulphoximine. Int. J. Cancer. 55:1993;521-527.
68. Isonishi S., Hom D. K., Eastman A., Howell B. Enhancement of sensitivity to platinum (II)-containing drugs by 12-0-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line. Br. J. Cancer. 69:1994;217-221.
69. Nehm'e A., Baskaran R., Aebi S., Fink D., Nebel S., Cenni B., Wang J. Y., Howell S. B., Christen R. D. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells and cisplatin. Cancer Res. 57:1997;3253-3257.